Literature DB >> 8399491

Recombinant LuIII autonomous parvovirus as a transient transducing vector for human cells.

I H Maxwell1, F Maxwell, S L Rhode, J Corsini, J O Carlson.   

Abstract

Recombinants based on the genome of the autonomous parvovirus, LuIII, were constructed by replacing the viral coding sequences in an infectious clone (pGLu883) by a luciferase or beta-galactosidase reporter, which was linked to the viral P4 promoter. In cells cotransfected with either of these constructs, together with a plasmid supplying LuIII nonstructural and capsid proteins, excision and replication of the recombinant genome occurred. Transducing virions accumulated in the culture medium of the cotransfected cells, as assayed by reporter activity in recipient cells exposed to this medium. Transducing activity could be neutralized by antiserum to LuIII. Production of replicative form DNA and transducing virions were observed following cotransfection of HeLa, 293, or NB324K cells, in increasing order of efficiency. When homology existed between the recombinant genome and sequences flanking the viral genes in the helper construct, concomitant production of replication-competent, cytopathic virus was sometimes observed. This could be minimized by removal of the left end homology from the helper; by this means, preparations of luciferase transducing virus were obtained free from replication-competent virus. With such preparations, we observed luciferase expression (declining after 3 days) for up to 7 days in recipient HeLa cells. Hybridization of the recombinant viral DNA with strand-specific luciferase probes indicated packaging of both strands (as reported for LuIII), but with a several-fold excess of the (-) strand. We suggest that transducing-autonomous parvoviruses will be useful in gene transfer applications, possibly including gene therapy when only transient expression is desired.

Entities:  

Mesh:

Year:  1993        PMID: 8399491     DOI: 10.1089/hum.1993.4.4-441

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  8 in total

1.  The infectivity and lytic activity of minute virus of mice wild-type and derived vector particles are strikingly different.

Authors:  Susanne I Lang; Stephanie Boelz; Alexandra Y Stroh-Dege; Jean Rommelaere; Christiane Dinsart; Jan J Cornelis
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  The capsid determinant of fibrotropism for the MVMp strain of minute virus of mice functions via VP2 and not VP1.

Authors:  I H Maxwell; A L Spitzer; F Maxwell; D J Pintel
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

3.  Replicating parvoviruses that target colon cancer cells.

Authors:  M Malerba; L Daeffler; J Rommelaere; R D Iggo
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

4.  Replication competent helper functions for recombinant AAV vector generation.

Authors:  L Cao; M During; W Xiao
Journal:  Gene Ther       Date:  2002-09       Impact factor: 5.250

5.  Symmetric-strand packaging of recombinant parvovirus LuIII genomes that retain only the terminal regions.

Authors:  J Corsini; J O Carlson; F Maxwell; I H Maxwell
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

6.  Chromosomal integration and homologous gene targeting by replication-incompetent vectors based on the autonomous parvovirus minute virus of mice.

Authors:  Paul C Hendrie; Roli K Hirata; David W Russell
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

Review 7.  Best of most possible worlds: Hybrid gene therapy vectors based on parvoviruses and heterologous viruses.

Authors:  Julia Fakhiri; Dirk Grimm
Journal:  Mol Ther       Date:  2021-04-05       Impact factor: 11.454

Review 8.  Fantastic AAV Gene Therapy Vectors and How to Find Them-Random Diversification, Rational Design and Machine Learning.

Authors:  Jonas Becker; Julia Fakhiri; Dirk Grimm
Journal:  Pathogens       Date:  2022-07-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.